dpp-4 and glp-1 together Cardiovascular effects of inhibition: Beyond GLP-1 receptor agonists and DPP-4
Description
AONs GLP-1 Study Is a Warning Shot and an Opening A 44% drop in heart events

UK guidance aligned with NICE and MHRA recommendations.

Visit our website: To nominate for Top Healthcare Technology CEOs of 2025, click here: Sign up for our free email newsletter at #HealthcareTechnology #DrugDelivery #GLP1 #ObesityCare #MedicalDevices #BiotechInnovation

GLP-1 RAs in combination with metformin showed even more weight loss and improvement in markers of hyperandrogenism

This guide explores prescription options, compounded alternatives, and how genetic and biomarker factors may inform provider conversations about suitability
| As part of its investor day on Thursday, Cigna's Evernorth arm announced an expansion to its GLP-1 management solution as well as the launch of a new behavioral health-focused medical group.
